EQS-News:  DEFENCE'S MELANOMA TARGETED VACCINE A1-REPRO

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous  DEFENCE’S MELANOMA TARGETED VACCINE A1-REPROGRAMMED MSC (ARM) CELL POTENCY VALIDATED 24.01.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.   ____________________________________________...

Related Keywords

Canada , Toronto , Ontario , Vancouver , British Columbia , Frankfurt , Brandenburg , Germany , Canadian , Sebastien Plouffe , Defence Therapeutics Inc , News Service , Distribution Services , Defence Therapeutics , Statement Regarding , Corporate News , Regulatory Announcements , Unofficial Market , Defence , Herapeutics , Nc , Key , Iscellaneous , Melanoma , Argeted , Vaccine , 1 Reprogrammed , Sc , Fell , Potency , Validated , Et Cest , The ,